Summary
The project aims to co-refine an existing media campaign and develop, test, and evaluate a multilevel communication strategy to increase enrollment in early-stage HIV vaccine clinical trials, particularly within marginalized communities.
Evaluating a Multilevel Communication Campaign to Increase HIV Vaccine Trial Enrollment
US · IL
National Institutes of Health (NIH)
grant
open
#nih-5R01MH132500-03
What they want
The work involves co-refining an existing media campaign, developing, testing, and evaluating a multilevel communication strategy to address barriers to participation in HIV vaccine trials and strengthen trustworthiness in marginalized communities. This includes combating misinformation, strengthening community engagement, and building on strategies from COVID-19 vaccine trials such as consumer-driven marketing, virtual town halls, listening sessions, and expert panels. Specific aims include identifying effective media campaign components, evaluating the strategy's impact on Phase I HIV vaccine trial registration, and determining its effect on public engagement with vaccines and vaccine trials.
Deliverables
- Co-refined media campaign
- Developed multilevel communication strategy
- Evaluation of the multilevel communication strategy's impact on Phase I HIV vaccine trial registration
- Assessment of public engagement with vaccines and vaccine trials
- Established robust strategies to improve diversity, equity, and inclusion in Phase 1 preventive HIV vaccine trials
Market context
inferred from NAICSR&D in Physical, Engineering, Life Sciences (except Nanotech & Biotech)
NAICS 541715
- US market size
- $95B
- Typical award
- $100K – $50M+
Typical buyers
DoDNSFNIHNASADOE
Commonly required
DCAA-compliant accountingITARCMMC L2
Advertising Agencies
NAICS 541810
- US market size
- $48B
- Typical award
- $25K – $5M
Typical buyers
DoD recruitingUSPSCities
Commonly required
8(a)WOSB
